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ABSTRACT 
Separations are key aspects of many modern analytical methods. Real world samples contain many analytes. Many analytical methods do not 
offer sufficient selectivity to be able to speciate all the analytes that might be present. Separation isolates analytes. Most separation methods 
involve separation of the analytes into distinct chemical species, followed by detection. Instrumental methods may be used to separate samples 
using chromatography, electrophoresis or field flow fractionation. The development of the pharmaceuticals brought a revolution in human 
health. These pharmaceutical would serve their intended only if they are free from impurities and administered in appropriate amount. To 
make drugs serve their purpose various chemical and instrumentation method were developed at regular intervals which are involved in the 
estimation of drugs. For this analytical instrumentation and methods plays an important role. This review highlights the role of the analytical 
instrumentation and analytical method in assessing the quality of the drug. The review highlights variety of analytical techniques such as 
chromatographic, spectroscopic, electrophoretic, titrimetric, microscopic and electrochemical and their corresponding methods that has been  
applied in the analysis of pharmaceuticals. Quality of pharmaceutical product largely depends upon the environment controls during its storage 
and handling. Each pharmaceutical product should be handled and stored under specified storage condition labelled on product information 
data sheet or product pack. Ion chromatography was based on the use of a low-capacity anion exchange separator column used with a basic 
eluent and a suppressor column. IC is a part of high-performance liquid chromatography used to separate and determine anions and cations.  
Keywords: Analytical techniques, Sample separation, Chromatography, Spectroscopy, Electrochemical method, Microscopically method, 
Sample handling, Sample determination Electrophoresis. 
 
Article Info: Received 09 May 2019;     Review Completed 21 June 2019;     Accepted 26 June 2019;     Available online 15 July 2019 
Cite this article as: 
Modebrlu U, Beny B, Srinivas R, Analytical Techniques in Pharmaceutical Analysis for Samples Separation, 
Characterization, Determination and its Handling, Journal of Drug Delivery and Therapeutics. 2019; 9(4):607-622   
http://dx.doi.org/10.22270/jddt.v9i4.3117                                                  
*Address for Correspondence:   
Modebrlu Ukamaka, Department of Pharmaceutical Analysis, Karnataka College of Pharmacy, Thirumenahalli Bangalore, India 
 
 
INTRODUCTION 
With the great development of analytical instruments, 
interesting analytes can be directly detected [1]. However, it 
still remains a great challenge for the detection and 
quantification of those analytes with low-abundance due to 
the restriction of instrumental detection limit and 
interferences of complicated matrix [2]. Biological samples 
are particularly complicated samples with matrix 
interference. Therefore, prior to the analysis of trace 
biological targets, it is imperative for the isolation, 
separation and purification of raw samples [3, 4]. Although 
electrophoresis is low cost and simple to manipulate, it 
usually takes relatively long time and has poor repeatability 
[5]. Ultrafiltration has high separation efficiency, but it fails 
to obtain dry powder of target analytes and the membrane of 
ultrafiltration may exhibit adsorption toward biological 
macromolecules [6]. Among these techniques, solid-phase 
extraction (SPE) is one of the most important and powerful 
techniques because of its outstanding selectivity and 
recovery [7]. Although traditional SPE techniques where the 
adsorbents are packed into columns have been applied in 
many successful cases, but it is not suitable for coping with 
samples containing suspended solid or fouling components 
[8]. Batch separation technique, during which the adsorbents 
are incubated directly with the samples, can solve the above 
problems. Many new materials such as nano-materials and 
mesoporous materials have been employed in this mode [9, 
10]. However, when using these materials as affinity 
adsorbents for the enrichment of biological target analytes, 
nonreversible adsorption and high-speed centrifugation are 
often unavoidable, which may result in sample loss and co-
precipitation of unwanted interferents despite of their ability 
to remove salts and other contaminants [11]. Consequently, 
the application of these advanced materials as adsorbents is 
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restricted to a great extent. Therefore, a rapid, convenient, 
gentle and efficient sample preparation is urgently needed 
for biological analysis. In this case, with the use of magnetic 
materials, magnetic separation techniques have shown their 
usefulness. Magnetic separation technique is a batch-scale 
technique based on functionalized magnetic materials [8,12]. 
Magnetic materials are adsorbents particularly suitable for 
biological macromolecules due to their large surface area, 
good biocompatibility, easy functionalization and convenient 
manipulation. In a typical process of magnetic separation, 
magnetic materials, which exhibit affinity toward the 
isolated structure, are mixed with a sample containing target 
compounds. Within a period of incubation, target compounds 
bind to the magnetic particles. The whole magnetic complex 
is subsequently separated from the sample using an extra 
magnetic field. After washing out the contaminants, the 
isolated target compounds can be eluted and used for further 
work [12,13]. Magnetic separation techniques have several 
advantages in comparison with standard separation 
techniques used in various areas of biosciences [14]. The 
separation of enantiomers is a field of ever-growing 
importance in chemical industries, pharma, and food, and 
getting more important in different fields of bioanalysis 
(environmental, clinical). The capabilities of super- or 
subcritical fluid chromatography (SFC) regarding the 
separation of enantiomers are widely recognized. Due to the 
orthogonality of SFC compared to commonly applied 
chromatographic techniques like reversed phase liquid 
chromatography (RPLC) or hydrophilic interaction liquid 
chromatography (HILIC) [15,16] combined with a new 
generation of more robust instruments, SFC is becoming the 
method of choice for enantiopurity analysis [17]. Not only 
analytical but also preparative-scale separations of 
enantiomers are common in pharmaceutical industries but 
getting more important in different fields of bioanalysis. For 
method development general screening and optimization 
strategies for fast chiral separations in modern supercritical 
fluid chromatography are necessary [18,19] The 
determination of drugs and related substances in biological 
samples such as whole blood, plasma, serum, tissues and 
cells is referred to as bioanalysis. This term was coined in the 
1970s in relation to various techniques designed for the 
study of pharmacokinetics of drugs [20,21]. To improve 
productivity, coupled with the increasing demands for green 
chemistry approaches in analytical determinations, the 
liquid-phase microextraction (LPME) method was 
introduced in the mid-to-late 1990s. This is a modified form 
of the LLE that utilizes microlitres of solvents for the 
extraction process. The LPME technique is able to overcome 
some of the problems that are often encountered in solid 
phase microextraction (SPME). These problems include, but 
are not restricted to, the bending of syringe, leaching of fibre 
coating material and the fragility of the fiber itself. The 
microextraction techniques received favorable responses 
and various modifications have been introduced, e.g., single-
drop microextraction (SDME), continuous-flow 
microextraction (CFME) and hollow-fiber liquid-phase 
microextraction (HF-LPME). Details of these techniques are 
described elsewhere [22–25]. The drugs which are marketed 
may have different dosage forms. Formulation can be 
categorized according to the route of administration [26]. 
 
 
 
Fig1. Original papers on applications of magnetic separation techniques for enrichment of protein, nucleic acid, cell, bioactive 
compound and immobilization of enzyme from 2003 to 2013 (These papers were obtained from the Science Cita-tion Index 
Expanded (SCIE) Database of the Institute for Scientific Information (ISI)during January 2003–December 2013.). 
 
2. Analytical Techniques for Sample Separation 
and its Determination 
2.1 Titrimetric Techniques 
Origin of the titrimetric method of analysis goes back to 
somewhere in the middle of the18th century. It was the year 
1835 when Gay-Lussac invented the volumetric methods 
which subsequently leads to the origin of term titration. 
Although the assay method is very old yet there are signs of 
some modernization, i.e., spreading of non-aqueous titration 
method, expanding the field of application of titrimetric 
methods to (very) weak acids and bases as well as 
potentiometric end point detection improving the precision 
of the methods. With the development of functional group 
analysis procedures titrimetric methods have been shown to 
be beneficial in kinetic measurements which are in turn 
applied to establish reaction rates. These are many 
advantages associated with these methods which include 
saving time and labor, high precision and the fact that there 
is no need of using reference standards. In the past 
titrimetric methods have been used for the determination of 
captopril [27], albendozole [28] and gabapentin [29] in 
commercial dosage forms. Sparfloxacin [30] was determined 
by the nonaqueous titration method. In addition to its 
application in drug estimation titrimetry has been used in 
the past for the estimation of degradation products of the 
pharmaceuticals [ 31]. 
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2.2    Chromatographic Techniques 
2.2.1 Thin Layer Chromatography 
Although an old technique yet it finds a lot of application in 
the field of pharmaceutical analysis. In thin layer 
chromatography, a solid phase, the adsorbent, is coated onto 
a solid support as a thin layer usually on a glass, plastic, or 
aluminium support. Several factors determine the efficiency 
of this type of chromatographic separation. First the 
adsorbent should show extreme selectivity toward the 
substances being separated so as to the dissimilarities in the 
rate of elution be large. For the separation of any given 
mixture, some adsorbents may be too strongly adsorbing or 
too weakly adsorbing. Table 1 lists a number of adsorbents 
in the order of adsorptive power. Thin layer 
chromatography is a popular technique for the analysis of a 
wide variety of organic and inorganic materials, because of 
its distinctive advantages such as minimal sample clean-up, 
wide choice of mobile phases, flexibility in sample 
distinction, high sample loading capacity and low cost. TLC is 
a powerful tool for screening unknown materials in bulk 
drugs [32]. It provides a relatively high degree of assertion 
that all probable components of the drug are separated. The 
high specificity of TLC has been exploited to quantitative 
analytical purpose using spot elution followed by 
spectrophotometric measurement. TLC has been utilized for 
the determination of some steroids [33], pioglitazone [34], 
celecoxib[35] and noscapine [36]. TLC plays a crucial role in 
the early stage of drug development when information about 
the impurities and degradation products in drug substance 
and drug product is inadequate. Various impurities of 
pharmaceuticals have been identified and determined using 
TLC [37, 38]. 
 
Table 1 Chromatographic adsorbents: (approximate order is shown in the table, since it depends upon the substance being 
adsorbed, and the solvent used for elution). 
Most strong adsorbent Alumina Al2O3 
 Charcoal C 
  Florisil MgO/SiO2 (anhydrous) 
Least strong adsorbent Silica gel SiO2 
Source:http://www.chem.wisc.edu/courses/342/Fall2004/TLC.pdf.   
 
 
2.2.2 High Performance Thin Layer Chromatography 
With the advancement of the technique, high performance 
thin layer chromatography (HPTLC) emerged as an 
important instrument in drug analysis. HPTLC is a fast 
separation technique and flexible enough to analyze a wide 
variety of samples. This technique is advantageous in many 
means as it is simple to handle and requires a short analysis 
time to analyze the complex or the crude sample cleanup. 
HPTLC evaluates the entire chromatogram with a variety of 
parameters without time limits. Moreover, there is 
simultaneous but independent development of multiple 
samples and standards on each plate, leading to an increased 
reliability of results. HPTLC has been used to quantitate 
drugs as ethinyl estradiol and cyproterone[39], alfuzosin[ 
40]and tramadol and pentazocine [41]. 
2.2.3 High-Performance Liquid Chromatography 
HPLC is an advanced form of liquid chromatography used in 
separating the complex mixture of molecules encountered in 
chemical and biological systems, in order to recognize better 
the role of individual molecules. It was in the year 1980, 
HPLC methods appeared for the first time for the assay of 
bulk drug materials [42]. As seen in Table2, this has become 
the principal method in USP XXVII [43] and to a lesser extent 
but one of the most widely used methods also in Ph. Eur. 
4[44]. The refractive index detector is the detector of choice 
when one needs to detect analytes with restricted or no UV 
absorption such as alcohols, sugars, carbohydrates, fatty 
acids, and polymers. Decent trace detection performance is 
secured through a low noise. This detector is having the 
lowest sensitivity among all detectors but suitable at high 
analyte concentrations. Lakshmi and Rajesh utilized the 
refractive index detector to analyze the content of volgibose 
in pharmaceutical formulations [45]. The electrochemical 
detector responds to the substances that are either 
oxidizable or reducible and the electrical output results from 
an electron flow triggered by the chemical reaction that 
takes place at the surface of the electrode. This detector was 
applied recently to analyze the content of glutathione in 
human prostate cancer cells and lung adenocarcinoma cells 
[46].One of the most sensitive detectors among the LC 
detectors is fluorescence detector. Typically its sensitivity is 
10–1000 times higher than that of the UV detector for strong 
UV absorbing materials used as an advantage in the 
measurement of specific fluorescent species in samples. One 
of the most important applications of fluorescence is the 
estimation of pharmaceuticals [47]. The application of 
various types of detector in HPLC is compared in Fig 2. It 
became the method-of-choice for analytical support in many 
stages of quality control and assurance within the 
pharmaceutical industry [48,49]. 
 
Fig 2 Usage of different detectors for HPLC analysis of drugs, 
Scale 0–100 represents use of the detector percentage. 
Source: R.N. Rao, V. Nagaraju. J. Pharm. Biomed. Anal. 2003, 
33, 335–377. 
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Table 2 Proportion of various analytical methods prescribed for the assay of bulk Drug materials in ph.Eur. 4 and USP XXVIL 
Method Ph. Eur 4(%) USP 27(%) 
HPLC 15.5 44 
GC 2 2.5 
Titration 69.5 40.5 
Acid- Base 57.5 29.5 
Aqueous Mixture 21 5.5 
Indicator 6.5 4.5 
Potentiometric                                  14.5   1 
Non aqueous     36.5      24 
Indicator 9.5 14 
Potentiometric  27 10 
Redox(Iodometry, Nitritometry,etc) 6.5 5.5 
Other (Complexometry,argentometry, etc) 5.5 5.5 
UV-Vis spectrophotometry 9.5 8.5 
Microbiological assay (antibiotics) 3 2.5 
Other( IR, NMR,Polarimetry,fluorimetry, 0.5 2 
Atomic absorption spectroscopy,polarography, gravimetry Etc)                                                                         
Source: S. Gorog/ Journal of pharmaceutical and Biomedical Analysis 36(2005)931-937. 
2.2.4 Gas Chromatography 
Moving ahead with another chromatographic technique, gas 
chromatography is a powerful separation technique for 
detection of volatile organic compounds. Combining 
separation and on-line detection allows accurate 
quantitative determination of complex mixtures, including 
traces of compounds down to parts per trillion in some 
specific cases. Gas liquid chromatography commands a 
substantial role in the analysis of pharmaceutical product 
[50]. The creation of high-molecular mass products such as 
polypeptides, or thermally unstable antibiotics confines the 
scope of this technique. Its main constraint rests in the 
comparative non-volatility of the drug substances therefore, 
derivatization is virtually compulsory. Recently, gas 
chromatography has been used for assay of drugs such as 
isotretinion [51], cocaine [52] and employed in the 
determination of residual solvents in betamethasone 
valerate [53]. 
2.2.5 Ion Exchange Chromatography 
Ion exchange chromatography (IEC) is based on electrostatic 
interactions between charged patches on the surface of 
biomolecules and oppositely charged functional groups 
attached to a stationary phase via a spacer arm. The 
interactions are strongest when the ionic strength of the 
surrounding buffer is low, and binding can be modulated by 
changes in ionic strength and pH. Charges on molecules in 
solution and on the IEC resin are balanced by counter-ions, 
for example, salt and buffer ions, which are displaced when 
the target molecule binds to the charged functional group on 
the resin. The net binding charge of the protein will be the 
same as that of the counter-ions displaced from the resin, 
hence the term “ion exchange” [54]. Desorption of the 
adsorbed molecule is commonly executed by increasing the 
ionic strength of the buffer, and thereby eluting the protein 
by ionic competition. Alternatively, elution can be done by 
changing pH, which will change the net charge of the protein. 
For a more detailed description of the IEC technique, 
[55].IEC has been employed for several decades for the 
separation of small inorganic ions. However, it was not until 
hydrophilic materials of large pore size were introduced in 
the late 1950s that IEC of biological macromolecules became 
a useful separation tool [56]. IEC has since been successfully 
employed for protein purification and is today one of the 
most commonly used chromatographic separation modes for 
purification of pharmaceutical proteins and peptides. Most 
industrial purification processes comprise one or several IEC 
steps. The reason for its success is that it is considered a 
robust method and the principles are well characterized and 
well understood. The IEC resins typically have high binding 
capacities and offer good, and controllable, selectivity. 
Another advantage is that elution is done under mild 
conditions in which biomolecules maintain their native 
structures. 
There are basically two different types of resins used for IEC. 
In cation exchange chromatography (CIEC), negatively 
charged ligands bind positively-charged molecules, whereas 
the opposite is true for anion exchange chromatography 
(AIEC). Overall, AIEC is the most frequently used type due to 
the fact that many recombinant proteins are acidic, and thus 
negatively charged at neutral pH. Furthermore, AIEC resins 
bind polynucleotides, DNA, and RNA (due to their negatively 
charged phosphate groups). AIEC is used for endotoxin and 
virus removal, and it is also a common method for virus and 
vaccine purification. IEC is very versatile for downstream 
processing of recombinant proteins, and can be used for 
capture as well as intermediate purification and polishing. In 
capture, the requirement for capacity andquantitative yield 
is predominant, whereas further downstream in 
intermediate purification and especially polishing, yield is 
often compromised by selecting conditions that deliver 
enhanced purity. Early in the purification process, the target 
molecule concentration is often low and IEC can be a very 
efficient concentration step, in addition to purifying the 
product. In most monoclonal antibody (mAb) purification 
platform processes, IEC contributes to at least one of two 
polishing steps following the Protein A affinity step [57,58]. 
For mAb polishing, CIEC is commonly used in bind-and-elute 
mode for the target molecule, which allows negatively 
charged impurities such as residual DNA, RNA, some host 
cell proteins (HCPs), leached Protein A, and endotoxin to be 
removed during loading or in the wash fraction. CIEC also 
has the power to separate antibody charge variants and 
aggregates during elution. Most mAbs are relatively basic 
molecules that enable the use of AIEC in flow-through (FT) 
mode for the product under conditions where viruses, DNA, 
leached Protein A, and acidic HCP bind. This can be done 
either using pure FT mode or under conditions where the 
target protein interacts weakly with the resin [59]. 
Examples 
Polishing of Mabs Using CIEC [60] 
This example describes a mAb polishing step using a high-
capacity CIEC resin, Capto S Impact. The mAb, an IgG1 with a 
pI of 8.4, was produced by CHO cells and initially purified by 
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direct capture using Protein A chromatography. In this case, 
no intermediate purification step was required. The 
polishing by CIEC was optimized for capacity and separation 
of mAb monomer from aggregates by varying the pH and salt 
concentration under binding and elution conditions. Process 
optimization resulted in a QB10% of 109 mg mAb/mL of 
resin at pH 5.0 and 50 mM NaCl in the loading buffer. Elution 
was performed by applying a linear salt gradient from 50 to 
400 mM NaCl for 20 column volumes (CV’s). At a sample 
load of 76 g mAb/L resin, corresponding to 70% of QB10, 
the aggregate concentration was reduced from 2%–3% to 
0.9%, the HCP concentration from >300 ppm to 170 ppm, 
and the concentration of leached Protein A from 3.6 to less 
than 1 ppm (i.e., below the limit of quantification), with a 
monomer yield of 93%. The chromatogram in Fig. 3 shows 
the good separation of mAb fragments, monomer, and 
aggregates. The fragments do not bind as strongly to the 
resin and consequently elute earlier in the gradient than the 
monomer. The aggregates, on the other hand, which have a 
higher net binding charge compared with the monomer, 
tend to interact more strongly with the resin and elute after 
the monomer in the gradient. 
Sample: MAb in 50 mM sodium acetate, 50 mM NaCl, pH 5.0 
Medium: Capto S ImpAct (B/E mode) 
Column: Tricorn 5/100 
Load: 76 mg MAb/mL medium (70% of QB10) 
Residence time: 5.4 min 
Binding buffer: 50 mM sodium acetate, 50 mM Nacl, pH 5.0 
Wash: 5 CV of binding buffer 
Elution buffer: 50 mM sodium acetate, 50 to 400 mM NaCl in 
20 CV 
System: ÄKTA system  
 
Fig. 3 Separation of mAb fragments and aggregates with 
Capto S Impact at high sample load. The green histogram 
shows the amount of fragments and the red histogram 
shows the amount of aggregates as the percentage of total 
protein amount in corresponding fraction. The light blue 
area under the UV trace corresponds to the pooled product 
fractions. Courtesy: GE Healthcare Bio-Sciences AB. 
Purification of Type 5 Adenovirus Using AIEC [61] 
Adenovirus was produced by HEK 293 cells in suspension. 
After cell harvest and lysis, the clarified supernatant 
containing virus was treated with Benzonase (Novagen, 
Madison, WI), and the pH was adjusted to 8.0, prior to 
capture on a high-capacity AIEC resin—Q Sepharose XL. The 
loading buffer for the capture step was 50 mM Tris, 2 mM 
MgCl2, 5% sucrose pH 8.0. After loading, a wash was 
performed with 300 mM NaCl in binding buffer, followed by 
elution using a linear gradient from 300 to 750 mM NaCl in 
three CVs. The collected viral peak from the Q Sepharose XL 
column (Fig. 4) was diluted to a conductivity of 
approximately 25 mS/cm and then further purified on a 
SOURCE 15Q column. In this second AIEC step, the column 
was washed with 300 mM NaCl in loading buffer followed by 
elution with a gradient from 300 to 600 mM NaCl for 3 CVs 
(Fig. 18.3B). The amount of free doublestranded DNA 
(dsDNA) was reduced from 13.0% to 1.6% over the SOURCE 
15Q step. Finally, the virus was buffer exchanged using a size 
exclusion chromatography (SEC) column. Process evolution 
from gradient to step elution for the AIEC steps was also 
carried out. The step elution variant was scaled up to pilot 
production, and later used for second adenovirus project. 
 
Fig. 4  After pH adjustment with 1 M TRIS, the virus in the 
lysis buffer was loaded directly onto the column at 113 
cm/h. Immediately following the load, the column was 
washed with 30% buffer B for at least one column volume or 
until a stable baseline was achieved. The virus (arrow) was 
eluted from the column with the use of a linear gradient to 
75% buffer B in three column volumes. (B) The diluted viral 
peak from the Q Sepharose XL column was then loaded onto 
a Source15Q column at a flow rate of 152 cm/h. Immediately 
following the load, the column was washed with 30% buffer 
B until a stable baseline was achieved. The virus was eluted 
from the column with the use of a linear gradient from 30% 
to 60% buffer B in three column volumes. Reproduced from 
Jendrek et al. Development of a production and purification 
method for type 5 adenovirus. BioProcess J. 5 (1) (2006) 37–
42 with permission. 
2.2.6 Supercritical Fluid Chromatography 
In general, modern SFC separations are mainly performed 
on packed columns rather than on capillary columns. 
Consequently, none of the publications reviewed inhere 
reported the use of capillary columns for enantioseparation. 
As also known from achiral SFC, the main component of a 
chiral SFC method is the column. This parameter, obviously, 
determines if a method has the potential to succeed or not. 
Unless a chiral stationary phase (CSP) is used, it is dead 
capital. The broad enantiorecognition ability of 
polysaccharide based CSPs are reported and methodical 
screening strategies were developed to give the analyst 
evidence or at least empirical based guidance [62,63]. Most 
of the chiral CSPs used in SFC are well known from chiral 
high performance liquid chromatography (HPLC). 
Noteworthy, chiral columns originally designed and 
marketed for chiral HPLC may easily be used in SFC as well 
[64,65]. Application of columns whose utilization is 
recommended with high proportion of water as MP ensuring 
three-dimensional formation by hydration may be 
questionable for use in SFC. This might be the case for some 
Modebrlu et al                                                                                                       Journal of Drug Delivery & Therapeutics. 2019; 9(4):607-622 
 
ISSN: 2250-1177                                                                                  [612]                                                                                 CODEN (USA): JDDTAO 
columns equipped with protein based chiral selectors (e.g. 
human serum albumin, α1-acid glycoprotein). Also, a lack of 
data and missing longtime experiences might keep column 
producers from recom-mending use in SFC officially. Thus, 
polysaccharide, cyclodextrin, and (glyco) protein based, as 
well as Pirkle-type CSPs are used in chiral SFC. General 
structure elements of these CSPs are exemplified in Fig 3. 
Although several types of CSPs and many brands are 
available on the market the dominating CSPs in chiral SFC 
are polysaccharide based. Former publications already 
pronounced the prominentrole of amylose and cellulose 
based CSPs [66,67–71]. 
 
Fig. 5. Structure of chiral stationary phases (CSPs) as 
examples of polysaccharide, cyclodextrin, (glyco-)protein, 
and Pirkle-type based CSPs, displayed are amylose tris-(3,5-
dimethylphenylcarbamate), i.e. polysaccharide based (upper 
left), vancomycin (protein, upper right),  β_-cyclodextrin 
(lower left), and Whelk-O1 (Pirkle-type, lower right). 
2.3 Electrophoresis 
The capillary electrophoresis separation current is 
decoupled from the electrospray current through the sheath 
liquid reservoir [72,73,74,75], as seen in Fig. 6A. The design 
minimizes dilution associated with a sheath liquid by using a 
taper glass nanospray emitter.An on-line enzyme reactor 
successfully integrated with capillary electrophoresis and 
mass spectrometry utilized a solid support for enzyme 
[72,73] or protein [75] entrapment. The device is based on a 
monolithic microreactor positioned in-capillary that is made 
of acrylamide [72,73] or sulfonated-silica [75]. The 
polyacrylamide-based microreactor proved to be a 
compatible platform for enzyme immobilization while 
maintaining enzyme activity [72,73]. These microreactors 
were employed for two different enzymes. Immobilized 
alkaline phosphatase facilitated the determination of protein 
phosphorylation [73]. A trypsin monolith was developed for 
on-line protein digestion in a cell lysate. The integrated 
system was compatible with a 300 pg sample size. The in-
line monolith microreactor decreased incubation time to 
minutes [72] as compare to off-line protein digestion, which 
required 24 h when performed in free solution [75]. This 
concept was expanded by using the in-capillary monolith to 
trap the targeted proteins rather than the trypsin [75]. The 
approach minimized the deactivation of the trypsin activity 
through immobilization to the capillary surface while 
preserving the benefits of on-line digestion. Additionally, the 
amount of digested proteins was not limited by the length of 
the immobilized enzymes zone in the capillary. This 
monolithic material contained sulfonate groups to facilitate 
electrostatic trapping and exhibited high surface area. Under 
acidic conditions, proteins were easily extracted from the 
crude sample and subject to multiple processing steps. The 
microreactor was used to reduce, alkylate, and digest 
entrapped proteins. Immobilizing the protein enables the 
use of larger concentrations of trypsin. Digestion of proteins 
derived from a cell lysate was completed in 10 min. The 
excellent efficiency of the capillary electrophoresis was well-
suited to separate the complex peptide digest as shown in 
Fig. 6A. The median separation efficiency of the peaks in the 
electropherogram was 240,000theoretical plates. Using a 
100 cm long capillary and a Q executive HF mass 
spectrometer, 975 proteins were identified from Xenopus 
laevis zygote homogenate. 
 
 
Fig. 6 Schematic of capillary zone electrophoresis coupled 
with mass spectrometry showing on-line protein digests. 
The schematic in A is of strong cation exchange based 
monolith based microreactor coupled with capillary zone 
electrophoresis mass spectrometry. The mass spectrum in B 
is of an on-line analysis of Xenopus laevis protein digests 
achieved by the set up used in A. Reprinted with permission 
from Z. Zhang, L. Sun, G. Zhu, O.F. Cox, P.W. Huber, N.J. 
Dovichi, Nearly 1000 Protein Identifications from 50 ng of 
Xenopus laevis Zygote Homogenate Using Online Sample 
Preparation on a Strong Cation Exchange Monolith Based 
Microreactor Coupled with Capillary Zone Electrophoresis, 
Analytical Chemistry 88(1) (2016)877–882. Copyright 2016 
American Chemical Society. 
2.4 Spectroscopic Techniques 
2.4.1 UV-VIS Spectrophotometry 
Another important group of methods which find an 
important place in pharmacopoeias are spectrophotometric 
methods based on natural UV absorption and chemical 
reactions [76]. Spectrophotometry is the quantitative 
measurement of the reflection or transmission properties of 
a material as a function of wavelength. The advantages of 
these methods are low time and labor consumption. The 
precision of these methods is also excellent. The use of UV–
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Vis spectrophotometry especially applied in the analysis of 
pharmaceutical dosage form has increased rapidly over the 
last few years [77-80]. The colorimetric methods are usually 
based on the following aspects: _ 
 Complex-formation reaction. 
 Oxidation-reduction process. 
 A catalytic effect. 
It is important to mention that colorimetric methods are 
regularly used for the assay of bulk materials. For example, 
the blue tetrazolium assay is used for the determination of 
corticosteroid drug formulations [81,82]. The colorimetric 
method is also exploited for the determination of cardiac 
glycosides and is presented in European Pharmacopoeia. 
Several approaches using spectrophotometry for 
determination of active pharmaceutical ingredients in bulk 
drug and formulations have been reported and details of 
these methods are recorded in Table 3. 
 
Table 3 Quantitative analysis of drugs in pharmaceutical formulations by UV–visible spectrophotometric procedures. 
Reagent used Name of drug ʎmax Reference 
m-Cresol Acetaminophen 640 Qureshi et al. (1992) 
p-Chloranilic acid Quetiapine fumarate 
Milrinone 
520 
519 
Vinay and Revenasiddappa (2012) 
2,3-Dichloro 5,6-dicyano1,4-
benzoquinone 
Duloxetine 
 Amlodipine besylate 
477 
580 
Toker and onal (2012) 
Rahman and Hoda (2003) 
Chloranil Dutasteride 
Lisinopril 
525 
520 
Kumar et al. (2012) 
Rahman et al. (2007) 
7, 7, 7, 8- Tetracyanoquinodimethane Lisinopril 
Alendronate sodium 
743 
840 
Rahman et al. (2005b) 
Raza and Haq (2011) 
Iodine Flunarizine 
dihydrochloride 
380 El Walily et al. (1995) 
Helmy et al. (2012) 
Potasium iodide and potassium iodate Irbesartan 352 Rahman et al. (2005b) 
Ninhydrine Pregabalin 402.6 Bali and Gaur (2011) 
Ascorbic acid Lisinopril 530 Rahman et al. (2005c) 
Folin ciocalteu phenol Oxcarbazepine 
Ampicillin, amoxycillin, 
and carbenicillin 
760 
750, 770, 750 
Gandhimathi and Ravi (2008) 
Ahmad et al. (2004) 
Tris buffer Diclofenac sodium 284, 305 Kramancheva et al. (1997) 
Sodium metavanadate Diltiazem HCl 750 Rahman and Azmi (2000) 
Bromothymol blue Rasagiline mesylate 414 Chennaiah et al. (2011) 
Bromophenol blue Rasagiline mesylate 414 Chennaiah et al. (2011) 
Bromocresol green Rasagiline mesylate 414 Chennaiah et al. (2011) 
Potassium permanganate in alkaline 
medium 
Isatin 60 ALOthman et al. (2013) 
Brucine-sulfanilic acid in H2SO4 
medium 
Nicorandil 410 Rahman et al. (2004) 
3-Methyl-2-benzothiazoline Nicorandil 560 Rahman et al. (2004) 
Cu (II) & eosin Carbinoxamine 538 Ramadan and Mandil (2006) 
Potassium ferricyanide and 
ammonium ferric sulfate 
Pantoprazole sodium 725 Rahman et al. (2006b) 
Chloramin T Zidovudine 
Verapamil HCl 
520 
425 
Basavaiah and Anil Kumar, 2007 
Rahman and Hoda (2002) 
 
2.4.2 Near Infrared Spectroscopy 
Near infrared spectroscopy (NIRS) is a rapid and non-
destructive procedure that provides multi component 
analysis of almost any matrix. In recent years, NIR 
spectroscopy has gained a wide appreciation within the 
pharmaceutical industry for raw material testing, product 
quality control and process monitoring. The growing 
pharmaceutical interest in NIR spectroscopy is probably a 
direct consequence of its major advantages over other 
analytical techniques, namely, an easy sample preparation 
without any pretreatments, the probability of separating the 
sample measurement position by use of fiber optic probes, 
and the expectation of chemical and physical sample 
parameters from one single spectrum. The major 
pharmacopoeias have generally adopted NIR techniques. The 
European Pharmacopoeia in chapter 2.2.40 [83] and United 
States pharmacopoeias (chapter 1119) [84] address the 
suitability of NIR instrumentation for application in 
pharmaceutical testing. 
2.4.3 Nuclear Magnetic Resonance Spectroscopy 
Since the first report appeared in 1996 [85] describing the 
use of NMR spectroscopy to screen for the drug molecules, 
the field of NMR based screening has proceeded promptly. 
Over the last few years, a variety of state-of-the art 
approaches have been presented and found a widespread 
application in both pharmaceutical and academic research. 
Recently NMR finds its application in quantitative analysis in 
order to determine the impurity of the drug [86], 
characterization of the composition of the drug products and 
in quantitation of drugs in pharmaceutical formulations and 
biological fluids [87,88], Many reviews on the application of 
NMR in pharmaceuticals have been published [89, 90]. 
 
2.4.4 Ion Mobility-Mass Spectrometery 
Ion mobility-mass spectrometry (IM-MS) has gained the 
attention of numerous researchers because of its unique 
ability to separate ions based on size, shape, or charge in 
Modebrlu et al                                                                                                       Journal of Drug Delivery & Therapeutics. 2019; 9(4):607-622 
 
ISSN: 2250-1177                                                                                  [614]                                                                                 CODEN (USA): JDDTAO 
addition to being coupled to a high mass accuracy time-of-
flight mass analyzer. There are several different types of ion 
mobility that have been utilized for glycopeptide analysis. 
Travelling wave ion mobility-mass spectrometry (TWIMS-
MS) [91], the most popular commercially available IM-MS 
instrument, has been used to thoroughly characterize an 
IgG1 mAb’s glycosylation heterogeneity profile with 
glycopeptides of each glycoform being readily identified [92]. 
Li et al. found that TWIMS could separate peptides from 
glycopeptides into distinct trend lines that could be used for 
predicting glycosylation status of other peptides; they also 
noted that ion mobility reduced chemical noise to allow for 
the detection of lower abundant ions [93]. TWIMS-MS has 
also been used to distinguish epimeric glycopeptides derived 
from Muc 2 [94 Fig. 7A]. Two isomeric glycopeptides, same 
peptide backbone but differing only in the attachment of 
either α-GlcNAc or α-Gal-NAc, were partially separated with 
TWIMS-MS; interestingly, multiple overlapping conformers 
were identified for each glycopeptide. The authors confirmed 
the identity of each glycopeptide by using CID-IMS-MS [Fig. 
7B]; the diagnostic oxonium ions were separated with 
TWIMS-MS, highlighting the utility and importance of 
characterizing product ions. High-field asymmetric wave ion 
mobility spectrometry (FAIMS) has also been used to rapidly 
separate coeluting isomeric O-linked glycopeptides, differing 
only in glycosylation site [Fig. 7C]. The coeluting peptides 
were separated by altering the correction voltage applied. 
Confirmation of the glycosylation sites was confirmed with 
electron transfer dissociation (ETD) [Fig. 7D and E]; the two 
glycosylation sites are readily identified by their diagnostic 
product ions [95]. The combination of FAIMS to separate 
isobaric peptides and ETD to confirm the glycosylati site has 
proven to be quite useful in analyzing complex glycopeptides 
mixtures.
 
 
 
 
 
Fig. 7 Separation and analysis of glycopeptides by ion mobility-mass spectrometry. 
[A]travelling wave ion mobility mass spectrometry (TWIMS) identified multiple conformers of the isobaric Muc2 glycopeptides 
(PTTTPITTTTTVTPTPTPTGTQT with GalNAc 19 and GlcNac 20). TWIMS was not able to differentiate between the two intact 
glycopeptides; (B) however, after CID; TWIMS-MS could distinguish the diagnostic oxonium ions from each Mucin glycopeptide. 
(C) High-field asymmetric wave ion mobility mass spectrometry (FAIMS-MS) separation of two isobaric O-linked glycopeptides, 
differing only in glycan site attachment. (D, E) Glycopeptide identity confirmed with ETD MS2; diagnostic c and z ions are 
indicated in blue and red. 
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2.5 Electrochemical Methods 
The application of electrochemical techniques in the analysis 
of drugs and pharmaceuticals has increased greatly over the 
last few years. The renewed interest in electrochemical 
techniques can be attributed in part to more sophisticated 
instrumentation and to increase the understanding of the 
technique themselves. Here the application of various 
electrochemical modes in the analysis of drugs and 
pharmaceuticals is presented in Table 4. Moreover, a large 
number of electroanalytical methods are available for 
quantification of pharmaceuticals. An amberlite XAD-2 and 
titanium dioxide nanoparticles modified glassy carbon paste 
was developed for the determination of imipramine, 
trimipramine and desipramine. The electrochemical 
behaviour of these drugs was investigated using cyclic 
voltammetry, chronocoulometry, electrochemical impedence 
spectroscopy and adsorptive stripping differential pulse 
voltammetry [96]. The capsaicin modified carbon nanotube 
modified basal-plane pyrolitic graphite electrode or p-
chloranil modified carbon paste electrodes have been 
developed for the determination of benzocaine and 
lidocaine. The electrochemically initiated formation of 
capsaicin-benzocaine adduct causes a linear decrease in the 
voltammetric signal corresponding to capsaicin which 
correlates to the added concentration of benzocaine [97]. A 
copper (II) complex and silver nanoparticles modified glassy 
carbon paste electrode was constructed and used for the 
determination of dopamine, levodopa, epinephrine and 
norepinephrine. The electrochemical behavior of these 
drugs was studied using cyclic voltammetry, electrochemical 
impedance spectroscopy, chronocoulometry and adsorptive 
stripping square-wave voltammetry techniques[98]. 
Adsorptive stripping differential pulse voltammetric method 
has been developed for the determination of venlafaxine and 
desvenlafaxine using Nafion-carbon nanotube composite 
glassy carbon electrode [99]. An electrochemical method 
based on potentiometric stripping analysis employing 
cryptand and carbon nanotube modified paste electrode has 
been proposed for the subnanomolar determination of 
bismuth [100]. 
 
Table 4: Determination of drug by various electrochemical techniques. 
Techniques  Drugs determined              Remark Reference 
  
 
 
 
Voltammetry 
Β-blockers drugs  Nafion-coated glassy carbon 
electrode 
Nigovic et al.(2011) 
Rosiglitazone Square wave adsorptive stripping 
voltammetry 
Al-Ghamdi and 
Hefnawy(2012) 
Leucovorin  Silver solid amalgam electrode  Selesovska et al.(2012) 
Secnidazole Cathodic adsorptive stripping 
voltammetry 
El-Sayed et al. (2010) 
Acetaminophen and tramadol  At glassy carbon paste electrode Sanghavi and 
Srivastava(2011a) 
 Dopamine  Differential pulse stripping 
voltammetry 
Abdoljavadi and 
Masrournia (2011) 
Atenolol Using nanoglod modified indium tin 
oxide electrode 
Goyal et al.(2005) 
 
 
Polrography  
Nifedipine  Jeyaseelan et al. (2011) 
Anti-cancer drug, vitamin k3  TasA et al. (2011) 
Ciclopirox olamine   Ibrahim and El-
Enany(2003) 
Amperometry 
 
Diclofenac  Gimenes et al. (2011) 
Verapamil  Ortuno et al.(2005) 
Potentiometry N-acetyl-L-Cysteine  Prkic et al.(2011) 
Pentoxifylline  Alarfaj and EL-Tohamy 
(2011) 
 
2.6 Microscopic Techniques 
2.6.1 Scanning Photoelectron Microscopy 
Scanning photoelectron microscopy (SPEM) is a 
microspectroscopic and spectromicroscopic technique 
measuring XPS at the µm scale and providing 
spectromicroscopic imaging data based on the XPS 
spectroscopic features(e.g. S2\_t2_ around 162.3eV 
[101,102]). It is one of the most useful techniques for 
investigation of surface electronic characteristics e.g. 
chemical bonding states and chemical potential shifts [103], 
and imaging with high spatial resolution [104]. SPEM 
provides high quality information from the top few nm of the 
sample surface with both high spatial and energy resolutions 
[104]. This is in contrast to scanning electron microscopy 
(SEM) and transmission electron microscopy (TEM) which 
provide very high spatial resolution, due to the shorter 
wavelengths of electron beams as compared to those of the 
X-rays used for SPEM and PEEM, but have poor 
spectroscopic capabilities in terms of energy resolution 
and/or surface sensitivity due to limited energy-filtered 
electron and photonemission. The primary strength of SPEM 
is its separate imaging and micro spectroscopy capabilities, 
which allow independent optimisation of energy resolution, 
lateral resolution and acquisition time for each mode [105]. 
Moreover, additional analysers for detecting e.g. transmitted, 
reflected or fluorescence signals can be attached to SPEM, 
further extending its analytical capabilities [106]. Fig. 5 
shows a schematic setup of the ESCA microscopy beamline at 
the Elettra synchrotron facility in Trieste, Italy. The role of 
the Fresnel zone plate optics (FZP) is to demagnify a beam 
spot to a diameter of 150 nm (or less). Because FZPs are a 
diffractive optic, an order sorting aperture (OSA) is put 
between the sample and FZP to cut off undesired diffraction 
orders [107]. Emitted photoelectrons are collected by a 
SPECS-PHOIBOS 100 hemispherical analyser and detected 
bya48-channel electron detector where each channel 
measures electrons with a specific (narrow) kinetic energy 
range defined by the selected energy window [104,108]. 
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Fig. 8. SPEM setup at Elettra, Trieste, Italy 
2.6.2 Photoemission Electron Microscopy 
Photoemission electron microscopy(PEEM),generally 
offering similar capabilities to SPEM, is a non-destructive, 
synchrotron-/laboratory-based spectromicroscopy 
technique and is also a unique surface sensitive instrument 
providing images with high spatial resolution and full field 
[109,110]. PEEM is easily moved and installed to fit different 
beam lines or even normal laboratory environments using 
laser or Hg lamp UV light sources. It is actually the only soft 
X-ray imaging technique that has been used more frequently 
in normal laboratories than at synchrotron beamlines [111]. 
The presence of the energy filter reduces the chromatic 
aberrations in the electron optics and enables the selection 
of optimum lens setting as well as the position and size of 
contrast and field aperture for high signal intensity, thereby 
improving the lateral resolution [112]. PEEM is regarded as 
the most promising approach to photoemission-based 
imaging with high lateral resolution [113]. Further 
advancement in resolution will be highly dependent upon 
improvements in instrumental electrical and mechanical 
stability, as well as the development of better detectors 
[114], to achieve a resolution below 1 nm [115]. 
2.7 Electrophoretic Methods 
Another important instrument essential for the analysis of 
pharmaceuticals is capillary electrophoresis (CE). CE is a 
relatively new analytical technique based on the separation 
of charged analytes through a small capillary under the 
impact of an electric field. In this technique solutes are 
perceived as peak as they pass through the detector and the 
area of individual peak is proportional to their concentration, 
which allows quantitative estimations. In addition to 
pharmaceutical studies it finds an application in the analysis 
of biopolymer analysis and inorganic ions. CE analysis is 
generally more effective, can be performed on a quicker time 
scale, requires only a small amount, lesser up to Nano liter 
injection volumes and in most cases, takes place under 
aqueous conditions. These four characteristics of CE have 
proven to be beneficial to many pharmaceutical applications. 
Several reports have appeared on the application of this 
technique in the routine drug analysis [116-118]. Capillary 
electrophoresis (CE) has long been employed for the rapid 
and reproducible separation and analysis of fluorescently 
labeled glycans and intact glycoproteins. CE has been 
employed for the rapid separation of glycopeptides before 
analysis by mass spectrometry. [119] developed a method 
utilizing CE coupled to ESI-orthogonal accelerating time-of-
flight mass spectrometry (CE-ESI-oaTOF-MS) to rapidly 
analyze N- and O-glycopeptides derived from erythropoietin 
(EPO), a commonly used glycoprotein hormone abused in 
athletic competitions. Their method also discovered a novel 
sulfated sialoform glycopeptide. Lew et al. developed a rapid 
method for therapeutic antibody quality control utilizing CE-
MS to analyze the tryptic digest of Trastuzumab; the relative 
abundance of 14-glycoforms on one glycopeptide were 
readily attained [120 Fig. 9]. Barroso et al. coupled CE-TOF-
MS and μLC-TOF-MS for a clinical research application; their 
method was able to detect the relative glycoform abundance 
of human Transferrin Tf glycopeptide to predict the alcohol 
dependence of individuals utilizing a small serum sample 
[121].
 
 
Fig. 9 Capillary electrophoresis mass spectrometry (CE-MS) of therapeutic antibody. CE-MS quantified 14-glycoforms on one 
glycopeptides from Trastuzumab. Reproduced with permission from Lew, C., Gallegos-Perez, J. L., Fonslow, B., Lies, M., & 
Guttman, A. (2015). Rapid level-3 characterization of therapeutic antibodies by capillary electrophoresis electrospray 
ionization mass spectrometry. Journal of Chromatographic Science, 53(3), 443–449. doi:10.1093/chromsci/bmu229. 
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2.8 Sample Handling 
2.8.1 Biological Specimens 
Once a drug is introduced into a biological system, it is 
subjected to the processes of absorption, distribution, 
metabolism, and excretion, which are subjects of 
pharmacokinetics. Some basic principles governing the 
interactions between drugs and the human biological 
system, including drug introduction, absorption, 
distribution, and excretion will be addressed. Such 
knowledge facilitates the proper selection of specimens for 
analysis, sample pretreatment, and analytical data 
interpretation. Various biological specimens, including 
plasma, serum, blood, urine, saliva, milk, sweat, breath, hair, 
nails, skin, tissues, feces and stomach contents, are available 
for drug analysis (Table 5). Blood and urine are the 
specimens most commonly used in clinical and forensic 
analyses. Drugs and their metabolites can generally be 
detected for a few hours to a few days in blood and urine 
(Fig. 10). Alternative specimens such as hair sweat and oral 
fluid (saliva) can provide unique and sometimes additional 
information. The advantages of these specimens include ease 
of sample collection and sample stability. In sampling from 
these specimens, factors that must be considered include 
collection method, collection time, and the characteristics of 
the individual (e.g., age, sex, circadian rhythm, before or 
after a meal or exercise, and season of the year). 
Furthermore, in storing biological specimens, it is necessary 
to consider the effects of temperature, pH, ionic strength, 
light, oxygen, humidity and enzymes. Factors and measures 
used to avoid contamination and alterations during 
sampling, storage and sample preparation are shown in 
Table 5. This section describes the characteristics, collection 
and handling of these specimens. 
Serum, Plasma and whole Blood 
Blood is perhaps the most useful type of biological sample 
for the identification and quantification of drugs and for the 
interpretation of toxicologically significant data. Blood is a 
complex fluid containing solubilized proteins, dissolved fats 
and salts, and suspended cells. The major constituents, the 
red blood cells (erythrocytes), can be separated from the 
clear fluid (plasma) 
 
Table 5: Biological specimens available for drug analysis 
 
1.Liquids and gases 
 Blood  Wholeblood,plasma,serum 
 Urine  
 Secretion and effusion  Saliva,tears,sweat,milk,cerebrospinal fluid, gastric juice, bile, semen, 
liquor amnii 
 Breath  
2.Solids and 
semisolids 
 Feces  
 Keratinaceous tissues  Hair, skin, nails. 
 Organs and other tissues  Brain,liver,lung,kidney,muscle,fat,bone,stomach contents 
          
 
 
Fig. 10 Approximate periods for detecting compounds in biologic specimens. 
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Table-6 Factors and measures for contaminations and alterations during sampling, storage and sample preparation in 
pharmaceutical and biomedical analysis by centrifugation. 
Contamination and 
adsorption 
Factors Measures 
       1.Contamination  
 Experimental apparatus  Washing of apparatus 
 Reagents(impurities, additives, 
decomposition compounds) 
 Conservation in alright container Environmental 
clarification 
 Enviroment(volatile materials, dust, 
microbial products, experimenter) 
 
2.Adsorption to experimental apparatus  Choice of appropriate material 
   Correction by addition of analogue 
 3.Drying and moisture    absorption  Operation in a closed system 
 
 
Chemical alteration 
 1.oxygen  Addition of antioxidants, chelating  agents 
 2.Temperature  Storage in liquid nitrogen, freezer or refrigerator 
 3.Moisture  Dry disposal of sample, addition to desiccant to container 
4.Light  Shading, use of brown vials 
 
 
Biological alteration 
1.Vital reactions, metabolism 
 
 Addition of metabolic inhibitor, storage at low 
temperature 
2.Enzymatic reactions 
 
 Addition of enzyme inhibitor, storage at low temperature 
3.Growth of microbes  Addition of fungicides, storage at low temperature 
 
 
If blood is allowed to stand without the addition of 
anticoagulating agents, the red cells will eventually clot and 
the resulting fluid, serum, can be decanted. In plastic tubes, 
clotting may be delayed for more than 1 hour and some 
hemolysis can take place. Plasma is obtained from blood 
collected with heparin or another anticlotting agent. Because 
heparin is a mucopolysaccharide and may interact with 
some analytes, ethylenediamine tetraacetic acid (EDTA) or 
other anticoagulant may be preferable.EDTA should not be 
used when analyzing metallic and organometallic 
compounds. As matrices for drug analysis, the significant 
difference between plasma and serum is that serum does not 
contain fibrinogen and several clotting factors (2.5%–5% of 
proteins).In general, plasma or serum is routinely used for 
drug analysis. A method developed for plasma can normally 
be applied without modification to serum. In contrast, whole 
blood may be the sample of choice when trying to detect the 
presence of a drug, or when quantitative information is 
needed during assays of deteriorated blood samples, where 
complete separation of plasma or serum from red cells is not 
possible. Dried blood spots are frequently analyzed. That is, 
small drops of whole blood are collected and airdried on 
filter paper prior to analysis. This technique can result in the 
cost-effective shipment and storage of samples at room 
temperature, with only a small volume of solvent (5 mL) 
needed to extract the analytes. A frequent drawback in blood 
collection is sample hemolysis, diluting analytes and 
interfering with serum assays. Because serum and plasma 
contain high concentrations of proteins, drugs may bind to 
these proteins to varying degrees, depending on the 
individual physicochemical properties of these drugs. In 
general, acidic and neutral drugs bind primarily to albumin, 
whereas basic drugs bind primarily to acid glycoprotein. 
Only free drug is available for extravascular distribution and 
elimination, as well as being able to cross cellular 
membranes and interact with drug receptors. Direct analysis 
of drugs in serum or plasma from which protein has been 
removed may therefore not reflect total drug concentration. 
Therefore, protein is often denatured prior to extraction 
with an organic solvent. Alternatively, an appropriate 
adjustment of pH may dissociate drugs strongly bound to 
proteins.[122-125]. 
Urine 
Urine is one of the most commonly used biological matrices 
for drug analysis, particularly because of its relative ease of 
collection. Usually, urine is sampled over a 24-h period into 
precleaned bottles. Preservatives may be required to 
stabilize the analyte, particularly if it is susceptible to 
bacterial degradation. To guarantee the stability of the urine, 
the time between sampling and analysis should be kept as 
short as possible. After through shaking, the urine is divided 
into several samples and the aliquots arefrozen immediately. 
As a matrix, urine has moderate complexity and usually 
contains both organic and inorganic constituents, as well as 
a relatively high salt content. Urine contents are highly 
variable, because of the dilution resulting from the body’s 
attempts to maintain water balance. Therefore, results 
obtained from urine samples are typically normalized by 
expressing drug concentration per gram creatinine. 
Compared with blood, plasma, or serum, urine is relatively 
free of protein, making possible the direct extraction of an 
analyte with an organic solvent. However, the interpretation 
of results obtained from urine samples is complicated by 
several factors, such as the amount of urine excreted, 
variations in pH and ionic strength, and the time lapse after 
intake of the drug. Variations in urine pH and ionic strength 
can affect the elimination of many drugs, as well as their 
extraction efficiency when effects on the drug’s acid/base 
balance are significant. The other components of the sample 
may compete with the analyte for adsorption to the 
extractant, further reducing the amount extracted. These 
problems may be controlled for by using an appropriate 
internal standard, or by adding a standard compound to 
normalize quantification. The internal standard should be 
structurally related to the other compounds. If urine 
samples must be significantly diluted prior to extraction, 
because of very high drug concentrations, matrix variability 
is less significant.[122-125] 
Saliva 
Saliva is a colorless fluid excreted into the oral cavity from 
three principle glands.  The parotid gland, exiting at the top 
of the mouth, secretes saliva derived mainly from blood 
plasma (serous fluid).  The sublingual glands, exiting at the 
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sides of the mouth, excrete both serous fluid and mucin. The 
submandibular glands, exiting at the base of the tongue, also 
excrete both serous fluid and mucin. Saliva is approximately 
99% water, 0.3% protein (mostly enzymes) and 0.3% mucin 
with the balance being salts. Mucin is responsible for the 
stickiness of saliva. The low protein concentration in saliva 
minimizes drug binding compared with plasma. Therefore, 
saliva can be used to estimate the actual, protein-unbound, 
circulating concentration of some drugs and their 
metabolites at the time of collection. The pH of unstimulated 
saliva ranges from 5.6–7.0, increasing with stimulation to a 
maximum of 8.0. Therefore, drug concentrations in saliva 
partially depend on the pH of the saliva and the degree of 
stimulation. Saliva must be collected under certain 
stimulation conditions, because saliva flow and composition 
vary over a 24-h period. Compared with urine collection, 
saliva collection is less invasive and causes fewer concerns 
about violation of privacy and adulteration of samples. 
Compared with blood, saliva samples can be directly 
analyzed without a prior extraction step. These advantages 
have promoted numerous investigations and several review 
articles on the suitability of saliva in TDM and in forensic 
applications. Saliva volume may be increased by stimulating 
saliva flow, for example by chewing gum; sucking on candy; 
placing citric acid on the tongue; adsorption on cotton rolls 
or administration of pilocarpine. Material for stimulation of 
saliva must be carefully selected because lipophilic drugs 
may be adsorbed onto the material. For identification 
purposes, adsorption could be employed to directly extract 
the drug from the saliva while inside the mouth. OraSure® 
both stimulates saliva flow and collects the saliva on an 
absorbent pad. Salisoft® tubes containing a polypropylene–
polyethylene swab are also used for collection of saliva by 
chewing. Other devices have been developed to collect saliva 
from selected glands by placing the end of the device over 
the gland and applying suction. Although selected gland 
secretions can reduce saliva/plasma ratios and minimize 
oral contamination, most studies utilize mixed saliva 
specimens because their collection is less invasive. 
Incubating collected saliva at room temperature may release 
CO2, increasing the pH and generating sediment. In addition, 
growth of bacteria in saliva may alter its composition. 
Therefore, if not analyzed immediately after collection, 
saliva must be stored in a freezer.[122-125] 
Hair 
Hair is frequently utilized for drug analysis as its collection is 
relatively noninvasive, and it provides a historical record of 
exposure, due to the relatively long lifetime of drugs in hair 
(Fig. 7). However, drug concentration may vary by hair type, 
due to variations in drug affinity. The primary advantage of 
hair as a matrix for analysis is that it is fairly nonpolar, 
thereby tending to adsorb tends to absorb parent drug 
molecules, as they are usually less polar than their 
metabolites. This makes hair an ideal matrix for the 
nonpolar extraction of analytes, particularly when the 
parent drug is extensively metabolized and often non 
detectable in other tissues. Hair patterns, colors, textures, 
diameter and growth rates vary considerably by gender, age 
and race/ethnicity, as well as at different areas of the body. 
The average rate of hair growth in the vertex region of the 
scalp is 0.44 mm/day (range, 0.38–0.48 mm) for men 
and0.45 mm/day (range, 0.4–0.55 mm/day) for women. 
Although the mechanisms of drug incorporation into hair 
have not been sufficiently clarified, drugs are thought to be 
distributed into hair by two processes: direct incorporation 
from blood into growing hair shafts and/or adsorption from 
other media such as sweat and smoke or powders from the 
environment. The most important considerations in hair 
sampling are collection from an anatomical location in which 
hairs are relatively uniform, collection at a uniform distance 
from the scalp, collection of a sufficient sample for the 
number of tests to be performed, prevention of 
contamination and accurate identification of the samples. 
Hair is mainly collected from an area at the back of the head, 
an area in which hair growth rate varies less than in other 
areas and the hair is less subject to factors associated with 
age and sex. At least 200–250 mg should be collected 
because of the relatively large interindividual variability. 
When head hair is not available or too short, pubic or axillae 
hairs could be collected. The problem of external 
contamination is very important, as people may be exposed 
to a smoky or dusty environment. Another important 
concern is the change in drug concentration induced by 
cosmetic hair treatments. Various pretreatment procedures 
for release of drugs from hair have been proposed including 
methanol sonication and incubation with 0.1–1.0 M sodium 
hydroxide, 0.1 M hydrochloric acid, water, buffers, 0.1% 
sodium dodecyl sulfate, acetone, pronase, methanol-5 M 
hydrochloric acid, proteinase K, and b-glucuronidase-
arylsulfatase. With the exception of methanol sonication, the 
resulting mixture from the pretreatment step must be 
further purified prior to analysis. [126-128]. 
2.8.2 Medicinal Plants 
Plant-derived medicines such as crude drugs and traditional 
Chinese medicines consist of complex matrices, with their 
size, color and shape varying among individual plants. These 
formulations may also contain molds and insects, due to 
contamination and inadequate storage. In analyzing plant-
derived medicines, it is first necessary to confirm the origin 
of the plants, the presence or absence of contaminants and 
their identity, and the state of dryness. Matrices of medicinal 
plants may be solid, particulate or a mixture of organic 
compounds in an aqueous solution, and may consist of many 
components, such as macromolecules and small molecules. 
Solid medicinal plants require only grinding before 
extraction, but may be freeze-dried to generate a 
homogeneous powder. Liquid samples are most often 
freeze-dried, but may also be treated as solid samples. 
Sonication during solvent extraction may also improve the 
recovery of active components from medicinal plants. 
Soxhlet, shaking, and stirring are the conventional 
techniques most commonly used for the extraction of active 
components from medicinal plants. Solid samples are 
frequently extracted with pure or aqueous methanol, 
ethanol, acetonitrile or acetone, with or without the addition 
of small amounts of acids, using simple soaking, mixing, 
shaking or Soxhlet extraction. [129-132]  
CONCLUSION 
The main aim of sample separation is to decrease the 
complexity of material mixture. Various techniques are used 
to carry out the separation of the material mixture. The 
review also highlights the advancement of the techniques 
beginning from the older titrimetric method and to 
advanced electrophoretic method. Sample determination is 
carry out by the above techniques mention such as 
titrimetric techniques, chromatographic techniques, and 
spectroscopic technique. The review highlights more about 
sample determination in electrochemical method, on which 
various compounds are been determined. Sample handling 
were explain by means of biological specimens on how the 
serum, plasma , urine , saliva and hair  can be stored, 
analysed and able to known their concentration based on 
their ph ranges. Pharmaceutical drugs are to serve the 
human to make them free from potential illness or 
prevention of the disease. For the medicine to serve its 
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intended purpose they should be free from impurity or other 
interference which harm humans. The review is aimed at 
focusing on separation, determination and handling of 
samples with various analytical instruments in the 
pharmaceutical analysis. 
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